Market News

Calumino, founded in 2014 in Sydney, specialises in providing affordable, intelligent infrared sensing technology. The company has developed a unique sensor platform based on micro-optical mechanical systems (MEMS), a subset of semiconductor technology. Unlike traditional infrared sensors, which are either low-resolution and inexpensive or high-quality and costly, Calumino’s sensors offer military-grade performance at a significantly […]

DeteQt, a Sydney University spin-off founded in 2020, is developing a revolutionary magnetic field sensor using quantum technologies combined with semiconductor innovations. The company’s goal is to create the smallest and most sensitive sensor available. Traditional magnetic field sensors are either too large, expensive, or not sensitive enough for precise applications like navigation. DeteQt’s breakthrough

PYC Therapeutics (ASX:PYC) has announced plans to advance its investigational drug candidate, PYC-003, into human clinical trials for Autosomal Dominant Polycystic Kidney Disease (PKD) in early 2025. This decision follows the completion of pre-clinical studies demonstrating safety, efficacy, and targeted delivery in animal models and patient-derived kidney cysts. PKD is a genetic disorder that causes

Web Travel Group (ASX:WEB) has reported mixed results for the half-year ending 30 September 2024, its first reporting period since the demerger of its B2C businesses. The demerger, finalised on 30 September, saw Web Travel retain its WebBeds B2B travel marketplace, while Webjet Group, now operating separately, took over the B2C divisions, including Webjet OTA

VeriQuantix, a new cybersecurity company, specializes in Quantum Link Verification, a cutting-edge technology designed to secure fiber optic communication networks. CEO Peter Baynes highlights the vulnerabilities of current fiber optic systems, especially in the “last mile,” where data breaches often go undetected. The company’s solution uses quantum principles, specifically entangled photons, to verify the trustworthiness

Novonix (ASX:NVX) has completed a fully underwritten $44.4m institutional placement, issuing approximately 74.1 million new shares at $0.60 each. The placement, aimed at institutional and sophisticated investors, was well-supported by existing shareholders and welcomed several new investors. Chairman Admiral Robert J Natter noted, “The support from institutional shareholders and major backer Phillips 66 highlights confidence

Empire Energy Group (ASX:EEG) has been on a roll recently, announcing approval of its environmental management plan and the commencement of drilling. Today, the company announced the execution of binding commitment letters with Macquarie Bank for a $65m financing package to advance the Beetaloo Basin projects. The funding comprises three facilities designed to support key initiatives,

Orthocell (ASX:OCC) has appointed Device Technologies Asia (DVT Asia) as the exclusive distributor of its nerve repair device, Remplir, in Singapore. This marks the product’s first major international expansion beyond Australia and New Zealand, where sales have shown significant growth. Orthocell is a regenerative medicine company focused on repairing bone and soft tissue injuries. Remplir,

US stocks climbed on Tuesday, with the S&P 500 and the Dow Jones reaching new highs as investors brushed off concerns about potential tariffs from President-elect Donald Trump. The Dow rose by 123.74 points, or 0.28 per cent, closing at 44,860.31, recovering from a drop of more than 300 points earlier in the session. The

European carmakers faced a turbulent day on Tuesday as shares fell across the sector in response to President-elect Donald Trump’s sweeping tariff announcement, Stellantis revealed plans to close its historic Luton plant, and frustrations emerged over stringent EU emissions mandates. Trump’s tariffs threaten supply chains Trump’s pledge to impose a 25% tariff on imports from